Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insulet : to Present at Upcoming Investor Conferences

08/26/2021 | 04:02pm EDT

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming virtual investor conferences:

  • The 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 1:20 p.m. (Eastern Time)
  • The Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 1:15 p.m. (Eastern Time)
  • The Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 2:00 p.m. (Eastern Time)

To listen to the live webcasts of the presentations, please visit investors.insulet.com/events. Replays of the webcasts will also be available following the event.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.


© Business Wire 2021
All news about INSULET CORPORATION
10/18INSULET : Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and ..
PU
10/18INSULET CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ..
AQ
10/18INSULET : Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and ..
BU
10/18Insulet Announces Management Changes
CI
10/04INSIDER SELL : Insulet
MT
10/04INSULET CORP : Other Events (form 8-K)
AQ
09/30INSULET : Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycem..
BU
09/30Insulet’S Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Gly..
CI
09/29INSULET : to Announce Third Quarter 2021 Financial Results on November 4, 2021
BU
08/26INSULET : to Present at Upcoming Investor Conferences
BU
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 084 M - -
Net income 2021 21,3 M - -
Net Debt 2021 258 M - -
P/E ratio 2021 927x
Yield 2021 -
Capitalization 20 893 M 20 893 M -
EV / Sales 2021 19,5x
EV / Sales 2022 16,1x
Nbr of Employees 1 900
Free-Float 99,6%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 303,35 $
Average target price 286,68 $
Spread / Average Target -5,49%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION16.84%20 893
ABBOTT LABORATORIES14.21%221 691
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION19.13%55 133
DEXCOM, INC.53.66%54 963